Condensed Consolidated Statements of Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Series Seed Preferred Stock Preferred Stock	Series A Preferred Stock Preferred Stock
Balance (in shares) at Dec. 31, 2020		2,542,000			734,000	7,212,000
Balance at Dec. 31, 2020	$ (12,432)	$ 1	$ 20,161	$ (32,595)		$ 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	36		36
Net loss	(5,476)			(5,476)
Balance (in shares) at Mar. 31, 2021		2,542,000			734,000	7,212,000
Balance at Mar. 31, 2021	(17,872)	$ 1	20,197	(38,071)		$ 1
Balance (in shares) at Dec. 31, 2020		2,542,000			734,000	7,212,000
Balance at Dec. 31, 2020	(12,432)	$ 1	20,161	(32,595)		$ 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(7,012)
Balance (in shares) at Jun. 30, 2021		2,542,000			734,000	7,212,000
Balance at Jun. 30, 2021	(19,369)	$ 1	20,236	(39,607)		$ 1
Balance (in shares) at Mar. 31, 2021		2,542,000			734,000	7,212,000
Balance at Mar. 31, 2021	(17,872)	$ 1	20,197	(38,071)		$ 1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	39		39
Net loss	(1,536)			(1,536)
Balance (in shares) at Jun. 30, 2021		2,542,000			734,000	7,212,000
Balance at Jun. 30, 2021	(19,369)	$ 1	20,236	(39,607)		$ 1
Balance (in shares) at Dec. 31, 2021		20,895,000
Balance at Dec. 31, 2021	136,406	$ 2	279,089	(142,685)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	1,781		1,781
Issuance of common stock upon exercise of warrants (in shares)		7,000
Issuance of common stock upon exercise of warrants	54		54
Issuance of common stock upon exercise of stock options (in shares)		40,000
Issuance of common stock upon exercise of stock options	244		244
Net loss	(13,857)			(13,857)
Balance (in shares) at Mar. 31, 2022		20,942,000
Balance at Mar. 31, 2022	124,628	$ 2	281,168	(156,542)
Balance (in shares) at Dec. 31, 2021		20,895,000
Balance at Dec. 31, 2021	$ 136,406	$ 2	279,089	(142,685)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	114,638
Net loss	$ (32,126)
Balance (in shares) at Jun. 30, 2022		21,017,000
Balance at Jun. 30, 2022	108,730	$ 2	283,539	(174,811)
Balance (in shares) at Mar. 31, 2022		20,942,000
Balance at Mar. 31, 2022	124,628	$ 2	281,168	(156,542)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	2,235		2,235
Issuance of common stock upon exercise of stock options (in shares)		75,000
Issuance of common stock upon exercise of stock options	136		136
Net loss	(18,269)			(18,269)
Balance (in shares) at Jun. 30, 2022		21,017,000
Balance at Jun. 30, 2022	$ 108,730	$ 2	$ 283,539	$ (174,811)